Immix Biopharma amends 8-K to clarify no deposits at Silvergate or Silicon Valley Bank

Immix Biopharma, Inc.

Filing corrects original 8-K's item number from 1.01 to 7.01 for Regulation FD disclosure.
Company confirms neither Immix nor its subsidiaries hold cash deposits or securities at Silvergate Bank or Silicon Valley Bank.
Disclosure addresses investor concerns during the March 2023 regional banking crisis.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.